Skip to main content

Dianthus Therapeutics, Inc.

DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001690585

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Dianthus Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+37 vs. Q2 2025
Shares held
46.8M
+7.72M (+19.7%) vs. Q2 2025
Total value
$1.84B
+$1.11B (+152.9%) vs. Q2 2025
New holders
51
43 more added
Sold out
14
34 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 140 institutions
Q1 2021: 90 institutionsQ2 2021: 97 institutionsQ3 2021: 93 institutionsQ4 2021: 94 institutionsQ1 2022: 93 institutionsQ2 2022: 75 institutionsQ3 2022: 72 institutionsQ4 2022: 54 institutionsQ1 2023: 52 institutionsQ2 2023: 46 institutionsQ3 2023: 30 institutionsQ4 2023: 39 institutionsQ1 2024: 76 institutionsQ2 2024: 74 institutionsQ3 2024: 91 institutionsQ4 2024: 96 institutionsQ1 2025: 99 institutionsQ2 2025: 103 institutionsQ3 2025: 140 institutionsQ4 2025: 166 institutionsQ1 2026: 241 institutionsQ2 2026: 269 institutions
Value heldQ3 2025: $1.84B
Q1 2021: $418.4MQ2 2021: $366.3MQ3 2021: $276.0MQ4 2021: $211.4MQ1 2022: $138.9MQ2 2022: $54.6MQ3 2022: $65.8MQ4 2022: $11.1MQ1 2023: $23.6MQ2 2023: $22.0MQ3 2023: $136.3MQ4 2023: $106.5MQ1 2024: $782.3MQ2 2024: $768.8MQ3 2024: $858.7MQ4 2024: $765.7MQ1 2025: $685.5MQ2 2025: $728.6MQ3 2025: $1.84BQ4 2025: $2.02BQ1 2026: $5.18BQ2 2026: $6.40B
Institutions holding DNTH and their total value by quarter
QuarterHoldersValue
Q2 2026269$6.40B
Q1 2026241$5.18B
Q4 2025166$2.02B
Q3 2025140$1.84B
Q2 2025103$728.6M
Q1 202599$685.5M
Q4 202496$765.7M
Q3 202491$858.7M
Q2 202474$768.8M
Q1 202476$782.3M
Q4 202339$106.5M
Q3 202330$136.3M
Q2 202346$22.0M
Q1 202352$23.6M
Q4 202254$11.1M
Q3 202272$65.8M
Q2 202275$54.6M
Q1 202293$138.9M
Q4 202194$211.4M
Q3 202193$276.0M
Q2 202197$366.3M
Q1 202190$418.4M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding DNTH in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc193,059$7.60M0.00%+28,746+17.5%Added
Logos Global Management LP200,000$7.87M0.78%+200,000New
Barclays PLC204,369$8.04M0.00%+139,548+215.3%Added
Alphabet Inc.208,697$8.21M0.34%00.0%Unchanged
Price T Rowe Associates Inc216,135$8.51M0.00%+205,443+1,921.5%Added
Goldman Sachs Group Inc218,771$8.61M0.00%−145,821−40.0%Reduced
Affinity Asset Advisors, LLC262,100$10.3M0.96%+262,100New
Tang Capital Management LLC264,692$10.4M0.40%00.0%Unchanged
Great Point Partners LLC265,803$10.5M4.37%+265,803New
Candriam Luxembourg S.C.A.301,428$11.9M0.06%+60,852+25.3%Added
Ikarian Capital, LLC346,001$13.6M3.09%+346,001New
Vivo Capital, LLC353,998$13.9M1.12%+353,998New
5AM Venture Management, LLC365,053$14.4M5.26%−619,672−62.9%Reduced
Nantahala Capital Management, LLC375,000$14.8M0.91%+375,000New
Balyasny Asset Management LLC443,703$17.5M0.04%+443,703New
Franklin Resources Inc450,311$17.7M0.00%+450,311New
Geode Capital Management, LLC536,415$21.1M0.00%+51,515+10.6%Added
Marshall Wace, LLP572,938$22.5M0.02%+572,938New
Sio Capital Management, LLC577,750$22.7M5.75%+341,680+144.7%Added
Catalio Capital Management, LP667,615$26.3M4.86%−78,912−10.6%Reduced
State Street Corp671,048$26.4M0.00%−149,089−18.2%Reduced
Silverarc Capital Management, LLC674,966$26.6M3.85%+579,160+604.5%Added
Polar Capital Holdings Plc748,003$29.4M0.14%+748,003New
Baker Bros. Advisors LP789,759$31.1M0.22%00.0%Unchanged
Braidwell LP835,057$32.9M0.97%+835,057New
Alliancebernstein L.P.852,384$33.5M0.01%−322,438−27.4%Reduced
VR Adviser, LLC960,803$37.8M2.13%−39,197−3.9%Reduced
Citadel Advisors LLC1,013,501$39.9M0.03%+348,457+52.4%Added
Vestal Point Capital, LP1,180,000$46.4M2.11%−2,020,000−63.1%Reduced
Bain Capital Life Sciences Investors, LLC1,315,892$51.8M3.44%−1,166,358−47.0%Reduced
BlackRock, Inc.1,340,091$52.7M0.00%−18,690−1.4%Reduced
Vanguard Group Inc1,642,198$64.6M0.00%+196,117+13.6%Added
TCG Crossover Management, LLC1,676,624$66.0M3.25%+175,000+11.7%Added
Point72 Asset Management, L.P.2,041,960$80.4M0.17%+649,443+46.6%Added
Octagon Capital Advisors LP2,416,667$95.1M14.85%+75,000+3.2%Added
Wellington Management Group LLP2,577,662$101.4M0.02%+2,503,311+3,366.9%Added
Ra Capital Management, L.P.2,866,733$112.8M1.39%00.0%Unchanged
Avidity Partners Management LP3,204,184$126.1M28.70%+1,461,282+83.8%Added
Fairmount Funds Management LLC3,307,191$130.1M11.71%+600,000+22.2%Added
FMR LLC5,970,638$234.9M0.01%+1,426,450+31.4%Added
Deep Track Capital, LP0$00.00%−2,233,148−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−115,425−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−75,079−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−43,381−100.0%Sold out
Squarepoint Ops LLC0$00.00%−30,709−100.0%Sold out
Paloma Partners Management Co0$00.00%−29,214−100.0%Sold out
XTX Topco Ltd0$00.00%−27,003−100.0%Sold out
Verition Fund Management LLC0$00.00%−22,945−100.0%Sold out
Intech Investment Management LLC0$00.00%−12,969−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−3,187−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−356−100.0%Sold out
Quarry LP0$00.00%−137−100.0%Sold out
IFP Advisors, Inc0$00.00%0Sold out
Riggs Asset Managment Co. Inc.0$00.00%−35−100.0%Sold out